Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: A report from the population-based blood donors study

Clinical Infectious Diseases

Volumn 45, Issue 8, 2007, Pages 975-982

  Chaturvedi, Anil K ^a,f   Wilson, Marianna ^c   Sanders Lewis, Kolby A ^c   Katki, Hormuzd A ^a   Urquhart, Nicole ^b   Walters, Michael A ^b   Miley, Wendell ^b   Cranston, Beverly ^d   Hanchard, Barrie ^d   Hisada, Michie ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

^e TAP Pharmaceuticals   (United States)

^f Viral Epidemiology Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; PHOSPHORUS; PLASMA PROTEIN; HELMINTH ANTIBODY; LACTATE DEHYDROGENASE; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; EOSINOPHIL COUNT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAMAICA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; NEUTROPHIL COUNT; PHOSPHATE BLOOD LEVEL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; URINALYSIS; VIRUS CARRIER; VIRUS LOAD; BLOOD; BLOOD ANALYSIS; CASE CONTROL STUDY; CYTOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; PROVIRUS; SEX DIFFERENCE; STRONGYLOIDIASIS; VIROLOGY;

ANTIBODIES, HELMINTH; ANTIBODIES, VIRAL; BLOOD; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD DONORS; CASE-CONTROL STUDIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAMAICA; L-LACTATE DEHYDROGENASE; LYMPHOCYTES; PROVIRUSES; SEX FACTORS; STRONGYLOIDIASIS; URINALYSIS; VIRAL LOAD;

EID: 34848862417     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521932     Document Type: Article

References (33)

1. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951-8.
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24:6058-68.
3. Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43:250-3.
4. Maloney EM, Cleghorn FR, Morgan OS, et al. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:167-70.
5. Ho GY, Nelson K, Nomura AM, Polk BF, Blattner WA. Markers of health status in an HTLV-I-positive cohort. Am J Epidemiol 1992; 136:1349-57.
6. Welles SL, Tachibana N, Orav EJ, Okayama A, Ishizaki J, Mueller NE. Changes in hematologic parameters among Japanese HTLV-I carriers. J Acquir Immune Defic Syndr 1994; 7:92-7.
7. Murphy EL, Wilks R, Morgan OS, et al. Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. Int J Epidemiol 1996; 25:1090-7.
8. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; (Suppl 1)13:S2-S7.
9. Murphy EL, Glynn S, Watanabe K, et al. Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:332-8.
10. Glynn SA, Murphy EL, Wright DJ, Sacher RA, Fridey J, Schreiber GB. Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: a prospective analysis. Arch Pathol Lab Med 2000; 124:550-5.
11. Maloney EM, Wiktor SZ, Palmer P, et al. A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children. Pediatrics 2003; 112:e136-42.
12. Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998; 92:3557-61.
13. Hisada M, Okayama A, Tachibana N, et al. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int J Cancer 1998; 77:188-92.
14. Carvalho EM, Da Fonseca PA. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26:487-97.
15. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-17.
16. Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60:146-9.
17. Robinson RD, Lindo JF, Neva FA, et al. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 1994; 169:692-6.
18. Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2006; 74:246-9.
19. Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000; 19:4954-60.
20. Porto AF, Neva FA, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23:503-7.
21. Porto AF, Santos SB, Muniz AL, et al. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2005; 191:612-8.
22. Satoh M, Kiyuna S, Shiroma Y, Toma H, Kokaze A, Sato Y. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Clin Exp Immunol 2003; 133:391-6.
23. Yao K, Hisada M, Maloney E, et al. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. J Infect Dis 2006; 193:427-37.
24. Hisada M, Stuver SO, Okayama A, et al. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004; 190:1605-9.
25. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66:749-52.
26. Tachibana N, Okayama A, Ishihara S, et al. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer 1992; 51:593-5.
27. Hisada M, Okayama A, Spiegelman D, Mueller NE, Stuver SO. Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Int J Cancer 2001; 91:497-9.
28. VanVeldhuisen PC, Walters M, Sawada T, et al. Seroincidence of human T-lymphotropic virus type I infection and characterization of sero-converters in Jamaican food handlers. J Acquir Immune Defic Syndr 2003; 33:387-92.
29. Maloney EM, Yamano Y, VanVeldhuisen PC, et al. Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. J Infect Dis 2006; 194:552-60.
30. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993; 167:57-65.
31. Arisawa K, Soda M, Akahoshi M, et al. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors. Jpn J Cancer Res 1998; 89:797-805.
32. Stuver SO, Tachibana N, Okayama A, Mueller NE. Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan. J Infect Dis 1996; 173:584-91.
33. Nera FA, Murphy EL, Gam A, Hanchard B, Figueroa JP, Blattner WA. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1. N Engl J Med 1989; 320:252-3.